Global GLP-1 Analogues Market Report 2024-2032: Market Expansion Driven by Innovation and Efficacy in Diabetes and Obesity Treatment - Single Dose and Zepbound Drive Market Domination
30 août 2024 04h55 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose,...
Global Diabetes and Obesity Therapeutics Market Research 2024 2028: GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
18 juil. 2024 04h48 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028" report has been added to ResearchAndMarkets.com's offering. This study...
Digital Health for Obesity: A $457.4 Billion Global Market by 2034 - Uncover the Segments and Countries Projected to Experience the Fastest Growth, Along with Profiles of the Leading Players
01 juil. 2024 09h25 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Global Digital Health for Obesity Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Obesity Pipeline Research 2024: Insights About 80+ Companies and 100+ Pipeline Drugs - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
26 juin 2024 09h29 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Obesity - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Obesity - Pipeline Insight, 2024" report...
Anti-obesity Medication Market Analysis 2024-2034 by Product, Mechanism of Action, Distribution Channel and Region - Global Industry Projected to Register 31.71% CAGR, Reaching $137.4 Billion by 2034
26 juin 2024 06h55 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market" report has been added to ResearchAndMarkets.com's offering.The global anti-obesity medication market accounted...
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%
04 juin 2024 04h17 HE
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis" report has been...
World Anti-obesity Drugs Market Analysis Report 2024-2034: Increasing Prevalence of Obesity, Utilization of Digital Platforms to Enhance Patient Engagement, Rising Awareness
21 mai 2024 03h17 HE
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Anti-obesity Drugs Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.Overall world revenue for Anti-obesity Drugs...
Digital Health for Global Obesity Market Analysis Report 2024-2030, Featuring MyFitnessPal, Teladoc, FitnessKeeper, PlateJoy, Tempus, Fitbit, Noom, WellDoc, Sidekick Health and BioAge Labs
14 mai 2024 08h32 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By End-use (Patients, Providers,...
Lifestyle Drugs Global Strategic Business Report 2024
13 mai 2024 09h11 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Lifestyle Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Lifestyle Drugs Market to Reach...
Weight Loss/Weight Management (Obesity) Pipeline Insight, 2024: Drugs Under Development, Unmet Needs, Key Players, Collaborations, Licensing Agreement and Financing Details
08 mai 2024 05h39 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss/Weight Management (Obesity) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...